2019
DOI: 10.1016/j.gore.2019.06.005
|View full text |Cite
|
Sign up to set email alerts
|

Paraneoplastic Cushing's syndrome and hypercalcemia arising from metastatic endometrioid endometrial adenocarcinoma: A case report

Abstract: Highlights Paraneoplastic Cushing's syndrome is rarely seen in gynecologic cancers, appearing only in case reports It almost universally results in acute decompensation and portends a poor prognosis We describe a patient with metastatic endometrial carcinoma with both paraneoplastic Cushing's syndrome and hypercalcemia High clinical suspicion for malignancy is essential, as these syndromes improve with treatment of the underlying maligna… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 15 publications
0
5
0
Order By: Relevance
“…According the literature, approximately two-third of the ovarian small cell carcinoma would co-occur with hypercalcemia. 13 In endometrial cancer, the occurrence of hypercalcemia is very rare, only few cases combined with HHM have been reported 14 17 ( Table 3 ). In our case, although the serum calcium level dropped after receiving medications, her condition was getting worse since the primary tumor was incapable to treat effectively.…”
Section: Discussionmentioning
confidence: 99%
“…According the literature, approximately two-third of the ovarian small cell carcinoma would co-occur with hypercalcemia. 13 In endometrial cancer, the occurrence of hypercalcemia is very rare, only few cases combined with HHM have been reported 14 17 ( Table 3 ). In our case, although the serum calcium level dropped after receiving medications, her condition was getting worse since the primary tumor was incapable to treat effectively.…”
Section: Discussionmentioning
confidence: 99%
“…PCS arises from tumour secretion of ACTH or CRH, resulting in production and release of cortisol from the adrenal glands. Unlike paraneoplastic endocrine syndromes that present most of the time after cancer diagnosis, PCS typically appears before cancer detection and similarly relapse may herald tumour recurrence [ 11 , 14 ]. In our case, no symptoms related to hypercortisolaemia led the patient to consult before obstructive syndrome.…”
Section: Discussionmentioning
confidence: 99%
“…PCS can cause a poor clinical outcome due to various complications with an increase in susceptibility to infection and GI ulceration. Indeed, for small-cell lung cancer and gynaecological malignancies, PCS is associated with accelerated decompensation and poorer response to chemotherapy (Mitchell et al [ 14 ]). Whether these findings can be extrapolated to other malignancies is unknown.…”
Section: Discussionmentioning
confidence: 99%
“…3 Importantly, ectopic ACTH and, rarely, cortisol secretion has been observed, resulting from gynaecological neuroendocrine tumours, endometrial adenocarcinomas and ovarian teratomas. [22][23][24] Symptoms are the classic Cushingoid phenotype, which may or may not be accompanied by electrolyte disturbance (hypokalaemia). These clinical findings may pre-date those of malignancy, with the underlying neoplasm being found in the diagnostic work-up.…”
Section: Cushing's Syndromementioning
confidence: 99%
“…Most cases (50–60%) are attributed to neuroendocrine lung tumours; for example, small cell carcinoma 3 . Importantly, ectopic ACTH and, rarely, cortisol secretion has been observed, resulting from gynaecological neuroendocrine tumours, endometrial adenocarcinomas and ovarian teratomas 22–24 . Symptoms are the classic Cushingoid phenotype, which may or may not be accompanied by electrolyte disturbance (hypokalaemia).…”
Section: Endocrine Paraneoplastic Syndromementioning
confidence: 99%